Torrent Pharma Q2 FY26 Results: Net Profit Soars 30.5% YoY to ₹591 Crore

aceuticals delivered robust growth in Q2 FY26, posting a net profit of ₹591 crore on November 7 — a 30.5% increase from ₹453 crore in the same quarter last year. Revenue from operations climbed over 14% YoY to ₹3,302 crore, fueled by strong sales in the US and Brazil markets. The Indian business continued its market-beating growth, though Germany saw a dip due to supply disruptions. EBITDA margin stood at 32.8%, in line with estimates, with both revenue and EBITDA beating consensus by 3%.